We have investigated the influence of interleukin 1 (IL-1) on growth o
f human renal carcinoma cells in vitro. Using a capillary soft-agar cl
oning system, 18% of freshly explanted renal carcinomas were stimulate
d to grow by IL-1 and 4% were inhibited. Subsequent experiments with e
stablished renal cancer cell lines demonstrated that two out of four c
ell lines (Caki-2, A-498) were sensitive to IL-1. [H-3]Thymidine incor
poration as well as monolayer growth was enhanced in Caki-2 cells in t
he presence of high (10%) and low (1%) serum concentrations. Although
clonogenic growth of A-498 cells was stimulated by IL-1, overall [H-3]
thymidine incorporation and monolayer proliferation were decreased. Us
ing radioligand experiments, 250 cell-surface receptors of high affini
ty (K-D 4.5 x 10(-11) M) and 2500 receptors of low affinity (K-D 1.3 x
10(-9) M) were detected on A-498 cells. IL-1 binding was reduced unde
r the influence of IL-1. Competition experiments with inhibiting antib
odies against IL-1 receptor type I and type II revealed that signal tr
ansduction was performed via type I receptors. After cross-linking to
IL-1, receptor type I was immunoprecipitated using anti-IL-1 antibodie
s. We hypothesise that, since IL-1 modulates in vitro growth of a subg
roup of human renal cancer cells, interference with its mechanism of a
ction may be of potential value in order to modulate tumour proliferat
ion.